RAYMOND W COHEN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for RAYMOND W COHEN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of RAYMOND W COHEN. RAYMOND W COHEN is a Director in BIOLIFE SOLUTIONS INC ($BLFS) and a CEO in CARDIAC SCIENCE INC ($DFIB) and a Chairman and CEO in CARDIAC SCIENCE INC ($DFIB) and a Director in SPECTRUM PHARMACEUTICALS INC ($SPPI) and an Chief Executive Officer in Axonics Modulation Technologies, Inc. ($AXNX).
Address: 1900 MAIN STREET SUITE 700 IRVINE 92614 CA
Companies in which RAYMOND W COHEN is an Insider
Axonics, Inc.
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of RAYMOND W COHEN: Chief Executive Officer
Holdings: 284,607 shares
Latest Transaction: Jun 10 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
BIOLIFE SOLUTIONS INC
Industry: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
Position of RAYMOND W COHEN: Director
Holdings: 22,763 shares
Current Value: $40,518
Latest Transaction: Nov 16 2020
$BLFS Market Capitalization: $23.31M
$BLFS Previous Close: $1.78
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
CARDIAC SCIENCE INC
Industry: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
Position of RAYMOND W COHEN: Chairman and CEO, CEO
Holdings: 0 shares
Latest Transaction: Sep 01 2005
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
SPECTRUM PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of RAYMOND W COHEN: Director
Holdings: 53,850 shares
Current Value: $267,096
Latest Transaction: Jun 21 2019
$SPPI Market Capitalization: $395.33M
$SPPI Previous Close: $4.96
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of RAYMOND W COHEN
Sentiment: All, AXNX, BLFS, DFIB, SPPI
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 10 2021 | AXNX | Axonics, Inc. | COHEN RAYMOND W | Chief Executive Off ... | Sell | S | 60.00 | 33,333 | 1,999,980 | 284,607 | 317.9 K to 284.6 K (-10.48 %) |
| May 12 2021 | AXNX | Axonics, Inc. | COHEN RAYMOND W | Chief Executive Off ... | Sell | S | 54.81 | 2,770 | 151,824 | 350,773 | 353.5 K to 350.8 K (-0.78 %) |
| May 12 2021 | AXNX | Axonics, Inc. | COHEN RAYMOND W | Chief Executive Off ... | Sell | S | 54.13 | 17,954 | 971,798 | 353,543 | 371.5 K to 353.5 K (-4.83 %) |
| May 12 2021 | AXNX | Axonics, Inc. | COHEN RAYMOND W | Chief Executive Off ... | Sell | S | 52.98 | 13,109 | 694,536 | 371,497 | 384.6 K to 371.5 K (-3.41 %) |
| Feb 02 2021 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Option Exercise | M | 0.00 | 16,667 | 0 | 0 | |
| Feb 02 2021 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Option Exercise | A | 0.00 | 42,500 | 0 | 42,500 | |
| Feb 02 2021 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Option Exercise | A | 0.00 | 20,000 | 0 | 20,000 |